Literature DB >> 17823285

Suppression of activation of signal transducer and activator of transcription-5B signaling in the vessel wall reduces balloon injury-induced neointima formation.

Venkatesh Kundumani-Sridharan1, Dong Wang, Manjula Karpurapu, Zhimin Liu, Chunxiang Zhang, Nagadhara Dronadula, Gadiparthi N Rao.   

Abstract

Previously, we have demonstrated that STAT-5B plays a role in thrombin-induced vascular smooth muscle cell (VSMC) growth and motility. To learn more about the role of STAT-5B in vessel wall remodeling, we examined its involvement in platelet-derived growth factor-BB (PDGF-BB)-stimulated VSMC growth and motility and balloon injury-induced neointima formation. PDGF-BB activated STAT-5B as measured by its tyrosine phosphorylation, DNA binding, and reporter gene activity. PDGF-BB induced cyclin D1 expression, CDK4 activity, and Rb protein phosphorylation, leading to VSMC growth and motility, and these responses were suppressed by the blockade of STAT-5B. Increased cyclin D1 levels, CDK4 activity, and Rb protein phosphorylation were observed in 1-week balloon-injured arteries compared with uninjured arteries, and these responses were also suppressed by adenovirus-mediated expression of dnSTAT-5B. In addition, adenovirus-mediated expression of dnSTAT-5B attenuated balloon injury-induced smooth muscle cell migration from media to intima and their proliferation in intima, resulting in reduced neointima formation. These observations indicate that STAT-5B plays an important role in PDGF-BB-induced VSMC growth and motility in vitro and balloon injury-induced neointima formation in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17823285      PMCID: PMC1988886          DOI: 10.2353/ajpath.2007.061258

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  49 in total

Review 1.  Living with or without cyclins and cyclin-dependent kinases.

Authors:  Charles J Sherr; James M Roberts
Journal:  Genes Dev       Date:  2004-11-15       Impact factor: 11.361

2.  Transcriptional regulation by a DNA-associated form of cyclin D1.

Authors:  Frédéric Bienvenu; Benjamin Barré; Sandrine Giraud; Sylvie Avril; Olivier Coqueret
Journal:  Mol Biol Cell       Date:  2005-01-19       Impact factor: 4.138

3.  Stat3 as an oncogene.

Authors:  J F Bromberg; M H Wrzeszczynska; G Devgan; Y Zhao; R G Pestell; C Albanese; J E Darnell
Journal:  Cell       Date:  1999-08-06       Impact factor: 41.582

4.  Transcriptional regulation of rat cyclin D1 gene by CpG methylation status in promoter region.

Authors:  S Kitazawa; R Kitazawa; S Maeda
Journal:  J Biol Chem       Date:  1999-10-01       Impact factor: 5.157

5.  Stent-based delivery of tissue inhibitor of metalloproteinase-3 adenovirus inhibits neointimal formation in porcine coronary arteries.

Authors:  Thomas W Johnson; Yin Xiong Wu; Christian Herdeg; Andreas Baumbach; Andrew C Newby; Karl R Karsch; Martin Oberhoff
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-01-27       Impact factor: 8.311

6.  Transcriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine-dependent growth of hematopoietic cells.

Authors:  I Matsumura; T Kitamura; H Wakao; H Tanaka; K Hashimoto; C Albanese; J Downward; R G Pestell; Y Kanakura
Journal:  EMBO J       Date:  1999-03-01       Impact factor: 11.598

7.  The NF2 tumor suppressor gene product, merlin, inhibits cell proliferation and cell cycle progression by repressing cyclin D1 expression.

Authors:  Guang-Hui Xiao; Ryan Gallagher; Justin Shetler; Kristine Skele; Deborah A Altomare; Richard G Pestell; Suresh Jhanwar; Joseph R Testa
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

8.  all-Trans-retinoic acid reduces neointimal formation and promotes favorable geometric remodeling of the rat carotid artery after balloon withdrawal injury.

Authors:  J M Miano; L A Kelly; C A Artacho; T A Nuckolls; R Piantedosi; W S Blaner
Journal:  Circulation       Date:  1998-09-22       Impact factor: 29.690

9.  Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses.

Authors:  S Teglund; C McKay; E Schuetz; J M van Deursen; D Stravopodis; D Wang; M Brown; S Bodner; G Grosveld; J N Ihle
Journal:  Cell       Date:  1998-05-29       Impact factor: 41.582

10.  STAT-3-dependent cytosolic phospholipase A2 expression is required for thrombin-induced vascular smooth muscle cell motility.

Authors:  Nagadhara Dronadula; Zhimin Liu; Chunmei Wang; Huiqing Cao; Gadiparthi N Rao
Journal:  J Biol Chem       Date:  2004-11-16       Impact factor: 5.157

View more
  9 in total

1.  Thymidine phosphorylase inhibits vascular smooth muscle cell proliferation via upregulation of STAT3.

Authors:  Hong Yue; Kuniyoshi Tanaka; Tatsuhiko Furukawa; Sadashiva S Karnik; Wei Li
Journal:  Biochim Biophys Acta       Date:  2012-06-02

2.  Protein kinase N1 is a novel substrate of NFATc1-mediated cyclin D1-CDK6 activity and modulates vascular smooth muscle cell division and migration leading to inward blood vessel wall remodeling.

Authors:  Nikhlesh K Singh; Venkatesh Kundumani-Sridharan; Sanjay Kumar; Shailendra K Verma; Sivareddy Kotla; Hideyuki Mukai; Mark R Heckle; Gadiparthi N Rao
Journal:  J Biol Chem       Date:  2012-08-13       Impact factor: 5.157

3.  Cyclin D1 is a bona fide target gene of NFATc1 and is sufficient in the mediation of injury-induced vascular wall remodeling.

Authors:  Manjula Karpurapu; Dong Wang; Dong Van Quyen; Tae-Kang Kim; Venkatesh Kundumani-Sridharan; Srinidhi Pulusani; Gadiparthi N Rao
Journal:  J Biol Chem       Date:  2009-11-22       Impact factor: 5.157

4.  An essential role for SRC-activated STAT-3 in 14,15-EET-induced VEGF expression and angiogenesis.

Authors:  Sergey Y Cheranov; Manjula Karpurapu; Dong Wang; Baolin Zhang; Richard C Venema; Gadiparthi N Rao
Journal:  Blood       Date:  2008-04-11       Impact factor: 22.113

5.  Src-dependent STAT-3-mediated expression of monocyte chemoattractant protein-1 is required for 15(S)-hydroxyeicosatetraenoic acid-induced vascular smooth muscle cell migration.

Authors:  Harihara S K Potula; Dong Wang; Dong Van Quyen; Nikhlesh K Singh; Venkatesh Kundumani-Sridharan; Manjula Karpurapu; Edwards A Park; Wayne C Glasgow; Gadiparthi N Rao
Journal:  J Biol Chem       Date:  2009-09-07       Impact factor: 5.157

Review 6.  STAT5a/b contribute to sex bias in vascular disease: A neuroendocrine perspective.

Authors:  Pravin B Sehgal; Yang-Ming Yang; Huijuan Yuan; Edmund J Miller
Journal:  JAKSTAT       Date:  2015-09-18

7.  Nuclear factor of activated T cells c1 mediates p21-activated kinase 1 activation in the modulation of chemokine-induced human aortic smooth muscle cell F-actin stress fiber formation, migration, and proliferation and injury-induced vascular wall remodeling.

Authors:  Venkatesh Kundumani-Sridharan; Nikhlesh K Singh; Sanjay Kumar; Ravisekhar Gadepalli; Gadiparthi N Rao
Journal:  J Biol Chem       Date:  2013-06-04       Impact factor: 5.157

8.  Novel interactions between NFATc1 (Nuclear Factor of Activated T cells c1) and STAT-3 (Signal Transducer and Activator of Transcription-3) mediate G protein-coupled receptor agonist, thrombin-induced biphasic expression of cyclin D1, with first phase influencing cell migration and second phase directing cell proliferation.

Authors:  Venkatesh Kundumani-Sridharan; Dong Van Quyen; Jaganathan Subramani; Nikhlesh K Singh; Y Eugene Chin; Gadiparthi N Rao
Journal:  J Biol Chem       Date:  2012-05-06       Impact factor: 5.157

9.  Suppression of JAK2/STAT3 signaling reduces end-to-end arterial anastomosis induced cell proliferation in common carotid arteries of rats.

Authors:  Jinbing Zhao; Meijuan Zhang; Wei Li; Xingfen Su; Lin Zhu; Chunhua Hang
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.